ALX Oncology Holdings Inc.
ALXO
$1.93
-$0.08-3.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 20.96M | 21.28M | 23.85M | 25.56M | 26.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 82.79M | 87.99M | 100.85M | 108.44M | 118.47M |
| Operating Income | -82.79M | -87.99M | -100.85M | -108.44M | -118.47M |
| Income Before Tax | -80.89M | -88.87M | -101.70M | -108.01M | -116.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -80.89 | -88.87 | -101.70 | -108.01 | -116.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -80.89M | -88.87M | -101.70M | -108.01M | -116.57M |
| EBIT | -82.79M | -87.99M | -100.85M | -108.44M | -118.47M |
| EBITDA | -81.77M | -86.82M | -99.62M | -107.15M | -117.11M |
| EPS Basic | -1.14 | -1.49 | -1.90 | -2.03 | -2.20 |
| Normalized Basic EPS | -0.71 | -0.89 | -1.15 | -1.23 | -1.34 |
| EPS Diluted | -1.14 | -1.49 | -1.90 | -2.03 | -2.20 |
| Normalized Diluted EPS | -0.71 | -0.89 | -1.15 | -1.23 | -1.34 |
| Average Basic Shares Outstanding | 348.07M | 265.88M | 214.67M | 213.18M | 212.30M |
| Average Diluted Shares Outstanding | 348.07M | 265.88M | 214.67M | 213.18M | 212.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |